|
CA2465978C
(en)
|
2001-09-14 |
2015-04-07 |
Soon Hyung Woo |
Inhibitors of histone deacetylase
|
|
US6897220B2
(en)
|
2001-09-14 |
2005-05-24 |
Methylgene, Inc. |
Inhibitors of histone deacetylase
|
|
US7868204B2
(en)
*
|
2001-09-14 |
2011-01-11 |
Methylgene Inc. |
Inhibitors of histone deacetylase
|
|
KR100581309B1
(ko)
|
2002-02-05 |
2006-05-22 |
아스텔라스세이야쿠 가부시키가이샤 |
2,4,6-트리아미노-1,3,5-트리아진 유도체
|
|
TWI319387B
(en)
*
|
2002-04-05 |
2010-01-11 |
Astrazeneca Ab |
Benzamide derivatives
|
|
GB0209715D0
(en)
*
|
2002-04-27 |
2002-06-05 |
Astrazeneca Ab |
Chemical compounds
|
|
US7154002B1
(en)
|
2002-10-08 |
2006-12-26 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
US7250514B1
(en)
|
2002-10-21 |
2007-07-31 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
US7351719B2
(en)
|
2002-10-31 |
2008-04-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds
|
|
US7169801B2
(en)
|
2003-03-17 |
2007-01-30 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
RU2330851C9
(ru)
|
2003-05-23 |
2008-10-20 |
Центарис Гмбх |
ПИРИДО[2,3-b]ПИРАЗИНОВЫЕ ПРОИЗВОДНЫЕ, ЛЕКАРСТВЕННОЕ СРЕДСТВО ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЯ ИЛИ НАРУШЕНИЯ, КОТОРЫЕ ОБУСЛОВЛЕНЫ НЕПРАВИЛЬНО НАПРАВЛЕННЫМИ ПРОЦЕССАМИ КЛЕТОЧНОЙ СИГНАЛЬНОЙ ТРАНСДУКЦИИ, СПОСОБ ПОЛУЧЕНИЯ ЛЕКАРСТВЕННОГО СРЕДСТВА
|
|
DE10323345A1
(de)
|
2003-05-23 |
2004-12-16 |
Zentaris Gmbh |
Neue Pyridopyrazine und deren Verwendung als Kinase-Inhibitoren
|
|
KR101204247B1
(ko)
|
2003-07-22 |
2012-11-22 |
아스텍스 테라퓨틱스 리미티드 |
3,4-이치환된 1ｈ-피라졸 화합물 및 그의 시클린 의존성키나제 (ｃｄｋ) 및 글리코겐 합성효소 키나제-3(ｇｓｋ-3) 조정제로서 용도
|
|
CA2536313A1
(en)
*
|
2003-08-22 |
2005-03-03 |
Takeda Pharmaceutical Company Limited |
Fused pyrimidine derivative and use thereof
|
|
AU2004276337B2
(en)
*
|
2003-09-24 |
2009-11-12 |
Methylgene Inc. |
Inhibitors of histone deacetylase
|
|
GB0322409D0
(en)
*
|
2003-09-25 |
2003-10-29 |
Astrazeneca Ab |
Quinazoline derivatives
|
|
US20050085531A1
(en)
*
|
2003-10-03 |
2005-04-21 |
Hodge Carl N. |
Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof
|
|
US7432281B2
(en)
|
2003-10-07 |
2008-10-07 |
Renovis, Inc. |
Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
|
|
CA2542096A1
(en)
*
|
2003-10-09 |
2005-04-21 |
Aton Pharma, Inc. |
Thiophene and benzothiophene hydroxamic acid derivatives
|
|
EP1680122A1
(en)
*
|
2003-10-16 |
2006-07-19 |
Chiron Corporation |
2,6-disubstituted quinazolines, quinoxalines, quinolines and isoquinolines as inhibitors of raf kinase for the treatment of cancer
|
|
US20050159470A1
(en)
*
|
2003-12-19 |
2005-07-21 |
Syrrx, Inc. |
Histone deacetylase inhibitors
|
|
WO2005066151A2
(en)
*
|
2003-12-19 |
2005-07-21 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
US7592373B2
(en)
|
2003-12-23 |
2009-09-22 |
Boehringer Ingelheim International Gmbh |
Amide compounds with MCH antagonistic activity and medicaments comprising these compounds
|
|
US20060019952A1
(en)
*
|
2004-01-29 |
2006-01-26 |
Elixir Pharmaceuticals, Inc. |
Anti-viral therapeutics
|
|
WO2005074643A2
(en)
*
|
2004-01-30 |
2005-08-18 |
Smithkline Beecham Corporation |
Benzamide compounds useful as rock inhibitors
|
|
DK1725528T3
(da)
|
2004-03-11 |
2013-09-02 |
4Sc Ag |
Sulfonylpyrroler som hdac-inhibitorer
|
|
TWI415606B
(zh)
*
|
2004-03-26 |
2013-11-21 |
Methylgene Inc |
組蛋白去乙醯基酶之抑制劑
|
|
JP5319113B2
(ja)
*
|
2004-03-26 |
2013-10-16 |
メチルジーン インコーポレイテッド |
ヒストンデアセチラーゼの阻害剤
|
|
US7253204B2
(en)
|
2004-03-26 |
2007-08-07 |
Methylgene Inc. |
Inhibitors of histone deacetylase
|
|
EP2543376A1
(en)
|
2004-04-08 |
2013-01-09 |
Targegen, Inc. |
Benzotriazine inhibitors of kinases
|
|
AR050926A1
(es)
*
|
2004-09-03 |
2006-12-06 |
Astrazeneca Ab |
Derivados de benzamida como inhibidores de la histonadesacetilasa(hdac)
|
|
US7776869B2
(en)
|
2004-10-18 |
2010-08-17 |
Amgen Inc. |
Heteroaryl-substituted alkyne compounds and method of use
|
|
EP1824831A2
(en)
|
2004-12-16 |
2007-08-29 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
GB0501146D0
(en)
*
|
2005-01-20 |
2005-02-23 |
Astrazeneca Ab |
Novel benzamide derivatives
|
|
US8404718B2
(en)
|
2005-01-21 |
2013-03-26 |
Astex Therapeutics Limited |
Combinations of pyrazole kinase inhibitors
|
|
AR054425A1
(es)
|
2005-01-21 |
2007-06-27 |
Astex Therapeutics Ltd |
Sales de adicion de piperidin 4-il- amida de acido 4-(2,6-dicloro-benzoilamino) 1h-pirazol-3-carboxilico.
|
|
KR20070097590A
(ko)
|
2005-01-25 |
2007-10-04 |
에픽스 델라웨어, 인코포레이티드 |
치환된 아릴아민 화합물 및 5―ｈｔ6 조절제로서의 이의용도
|
|
US7576099B2
(en)
|
2005-02-28 |
2009-08-18 |
Renovis, Inc. |
Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
|
|
WO2006097474A1
(en)
|
2005-03-15 |
2006-09-21 |
Nycomed Gmbh |
N-sulphonylpyrroles and their use as histone deacetylase inhibitors
|
|
CN101163471A
(zh)
|
2005-04-20 |
2008-04-16 |
默克公司 |
含有氨基甲酸酯、脲、酰胺和磺酰胺取代的苯并噻吩异羟肟酸衍生物
|
|
JP2008536925A
(ja)
|
2005-04-20 |
2008-09-11 |
メルク エンド カムパニー インコーポレーテッド |
ベンゾチオフェンヒドロキサム酸誘導体
|
|
EP1874295A4
(en)
*
|
2005-04-20 |
2009-08-12 |
Merck & Co Inc |
benzothiophene
|
|
JP2008540574A
(ja)
*
|
2005-05-11 |
2008-11-20 |
タケダ サン ディエゴ インコーポレイテッド |
ヒストンデアセチラーゼ阻害剤
|
|
EP1881835A4
(en)
*
|
2005-05-19 |
2010-04-07 |
Prometic Biosciences Inc |
TRIAZINE COMPOUNDS AND COMPOSITIONS THEREOF FOR THE TREATMENT OF CANCER
|
|
BRPI0610322B8
(pt)
|
2005-05-20 |
2021-05-25 |
Methylgene Inc |
inibidores de sinalização de receptor de vegf e de receptor de hgf e composição farmacêutica
|
|
US7417066B2
(en)
|
2005-06-08 |
2008-08-26 |
Schering Ag |
Inhibitors of soluble adenylate cyclase
|
|
DE102005027274A1
(de)
*
|
2005-06-08 |
2006-12-14 |
Schering Ag |
Inhibitoren der löslichen Adenylatzyklase
|
|
US20060281712A1
(en)
|
2005-06-14 |
2006-12-14 |
Chi-Feng Yen |
Pyrimidine compounds
|
|
US8193206B2
(en)
|
2005-06-14 |
2012-06-05 |
Taigen Biotechnology Co., Ltd. |
Pyrimidine compounds
|
|
JP4528918B2
(ja)
*
|
2005-06-21 |
2010-08-25 |
学校法人 関西大学 |
カルボキサミド誘導体
|
|
US8158825B2
(en)
|
2005-06-24 |
2012-04-17 |
Merck Sharp & Dohme Corp. |
Modified malonate derivatives
|
|
US7732475B2
(en)
*
|
2005-07-14 |
2010-06-08 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
EP1928437A2
(en)
|
2005-08-26 |
2008-06-11 |
Braincells, Inc. |
Neurogenesis by muscarinic receptor modulation
|
|
EP2258357A3
(en)
|
2005-08-26 |
2011-04-06 |
Braincells, Inc. |
Neurogenesis with acetylcholinesterase inhibitor
|
|
KR101314158B1
(ko)
|
2005-09-21 |
2013-10-04 |
4에스체 악티엔게젤샤프트 |
히스톤 탈아세틸 효소 억제제로서의 설포닐피롤 염산염
|
|
DK1928872T3
(da)
|
2005-09-21 |
2012-05-07 |
4Sc Ag |
Hidtil ukendte sulfonylpyrroler som inhibitorer af hdac
|
|
GB0521244D0
(en)
|
2005-10-19 |
2005-11-30 |
Astrazeneca Ab |
Benzamide compounds
|
|
AU2006304787A1
(en)
|
2005-10-21 |
2007-04-26 |
Braincells, Inc. |
Modulation of neurogenesis by PDE inhibition
|
|
WO2007053596A1
(en)
|
2005-10-31 |
2007-05-10 |
Braincells, Inc. |
Gaba receptor mediated modulation of neurogenesis
|
|
KR101467723B1
(ko)
|
2005-11-01 |
2014-12-03 |
탈자진 인코포레이티드 |
키나제의 비-아릴 메타-피리미딘 억제제
|
|
EP1790342A1
(de)
|
2005-11-11 |
2007-05-30 |
Zentaris GmbH |
Pyridopyrazin-Derivate und deren Verwendung als Modulatoren der Signaltransduktionswege
|
|
US8217042B2
(en)
|
2005-11-11 |
2012-07-10 |
Zentaris Gmbh |
Pyridopyrazines and their use as modulators of kinases
|
|
CA2628039A1
(en)
|
2005-11-11 |
2007-05-18 |
Aeterna Zentaris Gmbh |
Novel pyridopyrazines and their use as modulators of kinases
|
|
AR057579A1
(es)
|
2005-11-23 |
2007-12-05 |
Merck & Co Inc |
Compuestos espirociclicos como inhibidores de histona de acetilasa (hdac)
|
|
JP2009528354A
(ja)
|
2006-02-28 |
2009-08-06 |
メルク エンド カムパニー インコーポレーテッド |
ヒストン脱アセチル化酵素のインヒビター
|
|
US20100216734A1
(en)
|
2006-03-08 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
|
CA2648804C
(en)
|
2006-04-07 |
2014-05-27 |
Methylgene Inc. |
Benzamide derivatives as inhibitors of histone deacetylase
|
|
US8119685B2
(en)
|
2006-04-26 |
2012-02-21 |
Merck Sharp & Dohme Corp. |
Disubstituted aniline compounds
|
|
MX2008014320A
(es)
|
2006-05-09 |
2009-03-25 |
Braincells Inc |
Neurogenesis mediada por el receptor de 5-hidroxitriptamina.
|
|
EP2382975A3
(en)
|
2006-05-09 |
2012-02-29 |
Braincells, Inc. |
Neurogenesis by modulating angiotensin
|
|
AU2007254359A1
(en)
|
2006-05-18 |
2007-11-29 |
Merck Sharp & Dohme Corp. |
Aryl-fused spirocyclic compounds
|
|
CA2657288A1
(en)
|
2006-07-20 |
2008-01-24 |
Merck & Co., Inc. |
Phosphorus derivatives as histone deacetylase inhibitors
|
|
EP2068872A1
(en)
|
2006-09-08 |
2009-06-17 |
Braincells, Inc. |
Combinations containing a 4-acylaminopyridine derivative
|
|
US20100184806A1
(en)
|
2006-09-19 |
2010-07-22 |
Braincells, Inc. |
Modulation of neurogenesis by ppar agents
|
|
CN105481788A
(zh)
|
2006-10-28 |
2016-04-13 |
梅特希尔基因公司 |
组蛋白脱乙酰酶抑制剂
|
|
EP2425840B1
(en)
|
2006-12-15 |
2015-04-08 |
Abraxis BioScience, Inc. |
Triazine derivatives and their therapeutical applications
|
|
EP2132196A1
(en)
|
2007-02-26 |
2009-12-16 |
Pfizer Products Inc. |
Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
|
|
US8030344B2
(en)
*
|
2007-03-13 |
2011-10-04 |
Methylgene Inc. |
Inhibitors of histone deacetylase
|
|
AU2008269154B2
(en)
|
2007-06-27 |
2014-06-12 |
Merck Sharp & Dohme Llc |
4-carboxybenzylamino derivatives as histone deacetylase inhibitors
|
|
US8461189B2
(en)
|
2007-06-27 |
2013-06-11 |
Merck Sharp & Dohme Corp. |
Pyridyl derivatives as histone deacetylase inhibitors
|
|
JP5322477B2
(ja)
*
|
2007-09-28 |
2013-10-23 |
富士フイルム株式会社 |
新規アセチレン化合物、その塩、その製造方法、それを構成単位として含むポリマー、該ポリマーの製造方法、該ポリマーの組成物、該ポリマー組成物を硬化させてなる硬化物
|
|
CA2700058A1
(en)
|
2007-09-19 |
2009-03-26 |
4Sc Ag |
Novel tetrahydrofusedpyridines
|
|
MX2010003001A
(es)
*
|
2007-09-27 |
2010-04-01 |
Hoffmann La Roche |
Derivados de quinolina como antagonistas del receptor de la 5-hidroxitriptamina 5a.
|
|
WO2009047615A2
(en)
*
|
2007-10-10 |
2009-04-16 |
Orchid Research Laboratories Limited |
Novel histone deacetylase inhibitors
|
|
RU2453536C2
(ru)
*
|
2007-10-22 |
2012-06-20 |
Оркид Рисерч Лабораториз Лимитед |
Ингибиторы гистондезацетилазы
|
|
EP2060565A1
(en)
*
|
2007-11-16 |
2009-05-20 |
4Sc Ag |
Novel bifunctional compounds which inhibit protein kinases and histone deacetylases
|
|
EP2238103A1
(en)
*
|
2008-01-29 |
2010-10-13 |
F. Hoffmann-La Roche AG |
Novel n-(2-amino-phenyl)-amide derivatives
|
|
HRP20150932T2
(hr)
|
2008-04-21 |
2017-10-20 |
Taigen Biotechnology Co., Ltd. |
Heterociklički spojevi
|
|
JP2011519966A
(ja)
*
|
2008-05-16 |
2011-07-14 |
エフ．ホフマン−ラ ロシュ アーゲー |
新規なｎ−（２−アミノ−フェニル）−アクリルアミド
|
|
US8198271B2
(en)
|
2008-05-23 |
2012-06-12 |
Santen Pharmaceutical Co., Ltd. |
Thiophenediamine derivative having urea structure
|
|
GEP20125502B
(en)
|
2008-05-23 |
2012-04-25 |
Novartis Ag |
Derivatives of quinolines and quinoxalines as protein tyrosine kinase inhibitors
|
|
BRPI0913119A2
(pt)
|
2008-05-27 |
2015-07-28 |
Univ Texas |
Inibidores de sinalização de proteína wnt
|
|
WO2010028192A1
(en)
|
2008-09-03 |
2010-03-11 |
Repligen Corporation |
Compositions including 6-aminohexanoic acid derivatives as hdac inhibitors
|
|
US8202866B2
(en)
*
|
2008-09-17 |
2012-06-19 |
Hoffmann-La Roche Inc. |
Ortho-aminoanilides for the treatment of cancer
|
|
CN106243100B
(zh)
*
|
2008-10-10 |
2019-04-09 |
Vm生物医药公司 |
治疗酒精使用障碍，疼痛和其他疾病的药物组合与方法
|
|
MX2011004018A
(es)
|
2008-10-14 |
2011-06-24 |
Ning Xi |
Compuestos y metodos de uso.
|
|
TW201021855A
(en)
|
2008-11-13 |
2010-06-16 |
Taigen Biotechnology Co Ltd |
Lyophilization formulation
|
|
US8748623B2
(en)
*
|
2009-02-17 |
2014-06-10 |
Syntrix Biosystems, Inc. |
Pyridinecarboxamides as CXCR2 modulators
|
|
US20100216805A1
(en)
|
2009-02-25 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis using d-cycloserine combinations
|
|
CN101906076B
(zh)
*
|
2009-06-04 |
2013-03-13 |
深圳微芯生物科技有限责任公司 |
作为蛋白激酶抑制剂和组蛋白去乙酰化酶抑制剂的萘酰胺衍生物、其制备方法及应用
|
|
AU2010258974A1
(en)
*
|
2009-06-09 |
2012-01-12 |
California Capital Equity, Llc |
Pyridil-triazine inhibitors of hedgehog signaling
|
|
KR20120026612A
(ko)
|
2009-06-09 |
2012-03-19 |
아브락시스 바이오사이언스, 엘엘씨 |
벤질 치환 트리아진 유도체와 이들의 치료적 용도
|
|
AU2010258853B2
(en)
|
2009-06-09 |
2014-07-31 |
Nantbio, Inc. |
Triazine derivatives and their therapeutical applications
|
|
US8784873B2
(en)
*
|
2009-07-22 |
2014-07-22 |
Naturewise Biotech & Medicals Corporation |
Use of histone deacetylase inhibitors in changing MRJP3 protein in royal jelly
|
|
JP2011057661A
(ja)
*
|
2009-08-14 |
2011-03-24 |
Bayer Cropscience Ag |
殺虫性カルボキサミド類
|
|
CN102834002A
(zh)
|
2009-10-30 |
2012-12-19 |
麻省理工学院 |
Ci-994和地那林用于治疗记忆/认知和焦虑病症的用途
|
|
AU2011254550B2
(en)
|
2010-05-21 |
2013-11-07 |
Noviga Research Ab |
Novel pyrimidine derivatives
|
|
CA2811990C
(en)
*
|
2010-08-23 |
2023-03-21 |
Dean Y. Maeda |
Aminopyridine- and aminopyrimidinecarboxamides as cxcr2 modulators
|
|
WO2012060847A1
(en)
|
2010-11-07 |
2012-05-10 |
Targegen, Inc. |
Compositions and methods for treating myelofibrosis
|
|
US10059723B2
(en)
|
2011-02-28 |
2018-08-28 |
Biomarin Pharmaceutical Inc. |
Histone deacetylase inhibitors
|
|
EP2680694B1
(en)
*
|
2011-02-28 |
2019-01-02 |
BioMarin Pharmaceutical Inc. |
Histone deacetylase inhibitors
|
|
US9133162B2
(en)
|
2011-02-28 |
2015-09-15 |
Sunshine Lake Pharma Co., Ltd. |
Substituted quinoline compounds and methods of use
|
|
US8957066B2
(en)
|
2011-02-28 |
2015-02-17 |
Biomarin Pharmaceutical Inc. |
Histone deacetylase inhibitors
|
|
EP2688883B1
(en)
|
2011-03-24 |
2016-05-18 |
Noviga Research AB |
Pyrimidine derivatives
|
|
EP2508184A1
(en)
|
2011-04-06 |
2012-10-10 |
Æterna Zentaris GmbH |
Pyridopyrazine derivatives and their use
|
|
CN102775356B
(zh)
*
|
2011-05-13 |
2015-07-22 |
江苏恒谊药业有限公司 |
4-氨基喹唑啉衍生物及其应用
|
|
CN102807526B
(zh)
*
|
2011-06-21 |
2015-12-02 |
寿光富康制药有限公司 |
组蛋白去乙酰化酶抑制剂ZYJ-D08a及其差向异构体的制备方法与应用
|
|
CN102838625B
(zh)
*
|
2011-06-22 |
2015-04-15 |
中国科学院上海药物研究所 |
四氢吡啶并噻唑类化合物、其制备方法、包含该化合物的药物组合物及其用途
|
|
CN102276554B
(zh)
*
|
2011-06-28 |
2013-10-30 |
四川大学 |
4-（（2-氨基-5-巯基-1,3,4-噻二唑）-甲基）-苯甲酰胺衍生物及其制备方法和用途
|
|
EA201490228A1
(ru)
*
|
2011-07-08 |
2014-08-29 |
Новартис Аг |
Новые производные трифторметилоксадиазола и их применение для лечения заболевания
|
|
MX349712B
(es)
|
2011-07-29 |
2017-08-09 |
Karyopharm Therapeutics Inc |
Moduladores del transporte nuclear que contienen hidrazida y sus usos.
|
|
KR102022715B1
(ko)
*
|
2011-07-29 |
2019-09-18 |
카리오팜 쎄라퓨틱스, 인코포레이티드 |
핵 수송 조절인자 및 이의 용도
|
|
JP5966014B2
(ja)
*
|
2011-11-28 |
2016-08-10 |
ノバルティス アーゲー |
新規トリフルオロメチル−オキサジアゾール誘導体および疾患の処置におけるその使用
|
|
JP5881460B2
(ja)
*
|
2012-02-23 |
2016-03-09 |
公立大学法人名古屋市立大学 |
新規アミド化合物及びその用途
|
|
WO2013137371A1
(ja)
*
|
2012-03-15 |
2013-09-19 |
興和株式会社 |
新規ピリミジン化合物及びそれらを含有する医薬
|
|
KR102223028B1
(ko)
|
2012-05-09 |
2021-03-03 |
바이오젠 엠에이 인코포레이티드 |
핵 수송 조절인자 및 이의 용도
|
|
EP2854780B1
(en)
|
2012-06-05 |
2017-08-30 |
University Of Kansas |
Inhibitors of respiratory syncytial virus
|
|
US8969388B1
(en)
|
2012-07-28 |
2015-03-03 |
Sunshine Lake Pharma Co., Ltd. |
Substituted pyrazolone compounds and methods of use
|
|
TWI574962B
(zh)
|
2012-11-14 |
2017-03-21 |
加拓科學公司 |
作爲ｐｉ３激酶調節劑的芳雜環化合物及其使用方法和用途
|
|
US11639333B2
(en)
|
2012-12-21 |
2023-05-02 |
Celgene Quanticel Research, Inc |
Histone demethylase inhibitors
|
|
US9139583B2
(en)
|
2013-02-01 |
2015-09-22 |
Acetylon Pharmaceuticals, Inc. |
Selective HDAC3 inhibitors
|
|
WO2014121062A1
(en)
|
2013-02-01 |
2014-08-07 |
Acetylon Pharmaceuticals, Inc. |
Selective hdac3 inhibitors
|
|
SG11201505493QA
(en)
|
2013-02-21 |
2015-08-28 |
Calitor Sciences Llc |
Heteroaromatic compounds as pi3 kinase modulators
|
|
CN105121415B
(zh)
|
2013-03-15 |
2018-10-12 |
生物马林药物股份有限公司 |
Hdac抑制剂
|
|
US10202366B2
(en)
|
2013-03-15 |
2019-02-12 |
Karyopharm Therapeutics Inc. |
Methods of promoting wound healing using CRM1 inhibitors
|
|
EP3492455B1
(en)
|
2013-06-21 |
2023-05-17 |
Karyopharm Therapeutics Inc. |
1,2,4-triazoles as nuclear transport modulators and use in the treatment of specific forms of cancer
|
|
US10561676B2
(en)
|
2013-08-02 |
2020-02-18 |
Syntrix Biosystems Inc. |
Method for treating cancer using dual antagonists of CXCR1 and CXCR2
|
|
US10046002B2
(en)
|
2013-08-02 |
2018-08-14 |
Syntrix Biosystems Inc. |
Method for treating cancer using chemokine antagonists
|
|
US8969365B2
(en)
|
2013-08-02 |
2015-03-03 |
Syntrix Biosystems, Inc. |
Thiopyrimidinecarboxamides as CXCR1/2 modulators
|
|
EP2853532B1
(en)
*
|
2013-09-28 |
2020-12-09 |
Instytut Farmakologii Polskiej Akademii Nauk |
1,2,4-oxadiazole derivatives as allosteric modulators of metabotropic glutamate receptors belonging to group III
|
|
PE20160608A1
(es)
|
2013-10-14 |
2016-07-08 |
Eisai Randd Man Co Ltd |
Compuestos de quinolina selectivamente sustituida
|
|
AU2014334551B2
(en)
|
2013-10-14 |
2018-05-10 |
Eisai R&D Management Co., Ltd. |
Selectively substituted quinoline compounds
|
|
US10188756B2
(en)
|
2013-10-18 |
2019-01-29 |
The General Hospital Corporation |
Imaging histone deacetylases with a radiotracer using positron emission tomography
|
|
WO2015069693A1
(en)
*
|
2013-11-05 |
2015-05-14 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of histone deacetylase
|
|
US9636298B2
(en)
|
2014-01-17 |
2017-05-02 |
Methylgene Inc. |
Prodrugs of compounds that enhance antifungal activity and compositions of said prodrugs
|
|
DK3160952T3
(da)
|
2014-06-25 |
2021-03-08 |
Celgene Quanticel Res Inc |
Histone demethylase inhibitors
|
|
BR112017001918A2
(pt)
*
|
2014-07-31 |
2017-11-28 |
Pasteur Institut Korea |
derivados de 2-amino-benzimidazol e seu uso como inibidores de 5-lipoxigenase e/ou prostaglandina e sintase
|
|
KR102608259B1
(ko)
|
2014-08-15 |
2023-11-29 |
카리오팜 쎄라퓨틱스, 인코포레이티드 |
셀리넥소의 다형태
|
|
JP2018525342A
(ja)
|
2015-07-02 |
2018-09-06 |
バイオマリン ファーマシューティカル インコーポレイテッド |
ヒストンデアセチラーゼ阻害剤
|
|
EP3365344B1
(en)
|
2015-10-19 |
2020-12-09 |
Sunshine Lake Pharma Co., Ltd. |
(3-chloro-4-fluoro-phenyl)-(6-((4ar,7as)-3-(hexahydro-(1,4)dioxino(2,3-c)pyrrol-6-yl)-propoxy)-7-methoxy-quinazolin-4-yl)-amine di(methanesulfonic acid) salt and crystalline form of the monohydrate (a egfr inhibitor)
|
|
WO2017117535A1
(en)
|
2015-12-31 |
2017-07-06 |
Karyopharm Therapeutics Inc. |
Nuclear transport modulators and uses thereof
|
|
US10526295B2
(en)
|
2015-12-31 |
2020-01-07 |
Karyopharm Therapeutics Inc. |
Nuclear transport modulators and uses thereof
|
|
AU2017262920B2
(en)
*
|
2016-05-12 |
2021-05-20 |
Luoda Biosciences, Inc. |
Novel 2,4,6-trisubstituted s-triazine compound, preparation method therefor, and use thereof
|
|
CN106242992A
(zh)
*
|
2016-07-25 |
2016-12-21 |
北京化工大学 |
一种苯甲酰胺类化合物及其在制备抑制癌细胞增殖和/或治疗癌症的药物中的应用
|
|
CN106496053B
(zh)
*
|
2016-09-22 |
2018-01-05 |
潍坊医学院 |
一种组蛋白去乙酰酶抑制剂n‑(2’‑胺基苯基)‑4‑(双(2‑氯乙基)胺基)苯甲酰胺及其制备方法和应用
|
|
US10660909B2
(en)
|
2016-11-17 |
2020-05-26 |
Syntrix Biosystems Inc. |
Method for treating cancer using chemokine antagonists
|
|
US11602530B2
(en)
|
2016-11-28 |
2023-03-14 |
Biogen Ma Inc. |
CRM1 inhibitors for treating epilepsy
|
|
TW201829381A
(zh)
*
|
2016-12-22 |
2018-08-16 |
美商拜奧馬林製藥公司 |
組蛋白脫乙醯基酶抑制劑
|
|
US10357493B2
(en)
|
2017-03-10 |
2019-07-23 |
Selenity Therapeutics (Bermuda), Ltd. |
Metalloenzyme inhibitor compounds
|
|
US20180290977A1
(en)
|
2017-03-30 |
2018-10-11 |
Albert-Ludwigs-University Freiburg |
Kdm4 inhibitors
|
|
CN107141244B
(zh)
*
|
2017-05-08 |
2019-11-19 |
潍坊医学院 |
吲哚丁酸类组蛋白去乙酰酶抑制剂及其制备方法和应用
|
|
EP3624804B1
(en)
*
|
2017-05-16 |
2022-02-16 |
Annji Pharmaceutical Co., Ltd. |
Histone deacetylases (hdacs) inhibitors
|
|
US11230524B2
(en)
*
|
2017-08-17 |
2022-01-25 |
Standard Llc |
Myocyte enhancer factor 2 (MEF2) modulators
|
|
CN107459480A
(zh)
*
|
2017-09-05 |
2017-12-12 |
镇江斯格派医疗器械有限公司 |
一种双芳基脲类组蛋白去乙酰化酶抑制剂
|
|
KR101964810B1
(ko)
|
2017-10-12 |
2019-04-02 |
충북대학교 산학협력단 |
Hdac 억제제로서 신규한 퀴나졸린-4(3h)-원 기반 n-하이드록시벤즈아미드 또는 n-하이드록시프로펜아미드 및 이를 유효성분으로 포함하는 항암제 조성물
|
|
US12133852B2
(en)
|
2017-11-15 |
2024-11-05 |
Epivario, Inc. |
ACSS2 inhibitors and methods of use thereof
|
|
SG11202004318PA
(en)
|
2017-11-15 |
2020-06-29 |
Metabomed Ltd |
Acss2 inhibitors and methods of use thereof
|
|
CN108570012B
(zh)
*
|
2018-05-23 |
2021-11-12 |
中南大学 |
1,3-苯并噁嗪-2,4(3h)-二酮衍生物及其合成方法和用途
|
|
CN109020951B
(zh)
*
|
2018-08-24 |
2020-06-02 |
大连理工大学 |
含三取代三聚氯氰的萘酰亚胺类衍生物及其合成方法和应用
|
|
CN109336867A
(zh)
*
|
2018-10-31 |
2019-02-15 |
南京先进生物材料与过程装备研究院有限公司 |
咔唑类stat3抑制剂晶型a及其制备方法
|
|
CN109180656A
(zh)
*
|
2018-10-31 |
2019-01-11 |
南京先进生物材料与过程装备研究院有限公司 |
一类stat3抑制剂及其应用
|
|
CN109336876A
(zh)
*
|
2018-10-31 |
2019-02-15 |
南京先进生物材料与过程装备研究院有限公司 |
二苯并[b,d]噻吩类STAT3抑制剂的酒石酸盐及其制备方法与用途
|
|
CN110078722A
(zh)
*
|
2018-10-31 |
2019-08-02 |
南京先进生物材料与过程装备研究院有限公司 |
一种噻吨酮类stat3抑制剂马来酸盐晶型a及其应用
|
|
CN109336871A
(zh)
*
|
2018-10-31 |
2019-02-15 |
南京先进生物材料与过程装备研究院有限公司 |
一种stat3抑制剂的马来酸盐及其制备方法与用途
|
|
CN109336877A
(zh)
*
|
2018-10-31 |
2019-02-15 |
南京先进生物材料与过程装备研究院有限公司 |
二苯并[b,d]噻吩类STAT3抑制剂的甲磺酸盐及其制备方法与用途
|
|
CN109336870A
(zh)
*
|
2018-10-31 |
2019-02-15 |
南京先进生物材料与过程装备研究院有限公司 |
咔唑类stat3抑制剂晶型i及其制备方法
|
|
CN109369628A
(zh)
*
|
2018-10-31 |
2019-02-22 |
南京先进生物材料与过程装备研究院有限公司 |
咔唑类stat3抑制剂晶型ii及其制备方法
|
|
CN109293647A
(zh)
*
|
2018-10-31 |
2019-02-01 |
南京先进生物材料与过程装备研究院有限公司 |
二苯并[b,d]噻吩类STAT3抑制剂的M晶型及其制备方法
|
|
CN109369626A
(zh)
*
|
2018-10-31 |
2019-02-22 |
南京先进生物材料与过程装备研究院有限公司 |
咔唑类stat3抑制剂p晶型及其制备方法
|
|
CN109336869A
(zh)
*
|
2018-10-31 |
2019-02-15 |
南京先进生物材料与过程装备研究院有限公司 |
一种stat3抑制剂的甲磺酸盐及其制备方法与用途
|
|
EP3983386A4
(en)
|
2019-05-14 |
2023-01-11 |
Metabomed Ltd |
ACSS2 INHIBITORS AND METHODS OF USE THEREOF
|
|
EP4003319A4
(en)
|
2019-07-30 |
2023-11-08 |
Eikonizo Therapeutics, Inc. |
HDAC6 INHIBITORS AND THEIR USES
|
|
GB201918404D0
(en)
*
|
2019-12-13 |
2020-01-29 |
Z Factor Ltd |
Compounds and their use for the treatment of aplha1-antitrypsin deficiency
|
|
CN111116469A
(zh)
*
|
2019-12-27 |
2020-05-08 |
北京鑫开元医药科技有限公司 |
一种hdac抑制剂、制备方法、药物组合物及其用途
|
|
CN113549057B
(zh)
*
|
2020-04-24 |
2023-01-31 |
中国药科大学 |
Snail抑制剂及其衍生物，制备方法、药物组合物和应用
|
|
CN115403483B
(zh)
*
|
2021-07-02 |
2024-01-26 |
河南省儿童医院郑州儿童医院 |
含二苯乙烯或二苯甲酮骨架的ca-4衍生物、药物组合物及其制备方法和应用
|
|
CN114539180B
(zh)
*
|
2021-12-24 |
2025-02-07 |
贵州大学 |
一种含异噁唑啉的双酰胺类化合物及其制备方法和用途
|
|
CN118745163A
(zh)
*
|
2024-06-06 |
2024-10-08 |
四川省医学科学院·四川省人民医院 |
苯并呋喃类化合物、其制备方法及其应用和pdgfr激酶抑制剂
|